These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T cell immunity and vaccines against invasive fungal diseases. Ito JI Immunol Invest; 2011; 40(7-8):825-38. PubMed ID: 21815776 [TBL] [Abstract][Full Text] [Related]
4. The immune response to fungal infections. Shoham S; Levitz SM Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy: a potential adjunctive treatment for fungal infection. Kullberg BJ; van de Veerdonk F; Netea MG Curr Opin Infect Dis; 2014 Dec; 27(6):511-6. PubMed ID: 25304393 [TBL] [Abstract][Full Text] [Related]
6. Alarmin(g) the innate immune system to invasive fungal infections. Caffrey AK; Obar JJ Curr Opin Microbiol; 2016 Aug; 32():135-143. PubMed ID: 27351354 [TBL] [Abstract][Full Text] [Related]
7. In vitro systems for studying the interaction of fungal pathogens with primary cells from the mammalian innate immune system. Bourgeois C; Majer O; Frohner I; Kuchler K Methods Mol Biol; 2009; 470():125-39. PubMed ID: 19089381 [TBL] [Abstract][Full Text] [Related]
8. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Ben-Ami R; Lewis RE; Kontoyiannis DP Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330 [TBL] [Abstract][Full Text] [Related]
9. Aspergillus fumigatus: contours of an opportunistic human pathogen. McCormick A; Loeffler J; Ebel F Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206 [TBL] [Abstract][Full Text] [Related]
10. New insights into invasive aspergillosis--from the pathogen to the disease. Binder U; Lass-Flörl C Curr Pharm Des; 2013; 19(20):3679-88. PubMed ID: 23278533 [TBL] [Abstract][Full Text] [Related]
11. Fungal infections in hematopoietic stem cell transplant recipients. Marr KA Med Mycol; 2008 Jun; 46(4):293-302. PubMed ID: 18415836 [TBL] [Abstract][Full Text] [Related]
18. Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench. Chai LY; Vonk AG; Kullberg BJ; Netea MG Future Microbiol; 2011 Jan; 6(1):73-83. PubMed ID: 21162637 [TBL] [Abstract][Full Text] [Related]
19. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Chignard M; Balloy V; Sallenave JM; Si-Tahar M Clin Immunol; 2007 Sep; 124(3):238-43. PubMed ID: 17604224 [TBL] [Abstract][Full Text] [Related]
20. [Pathogenicity of Aspergillus and Candida (author's transl)]. de Haller R Prax Klin Pneumol; 1977 May; 31(5):539-45. PubMed ID: 887612 [No Abstract] [Full Text] [Related] [Next] [New Search]